Press Release by Industry
- All Industries
- Agriculture
- Automotive
- Banking
- Business Technology
- Construction
- Consumer Goods
- Consumer Technology
- Education
- Energy
- Entertainment & Media
- Environment
- Financial Services
- Food and Beverage
- General Business
- Healthcare
- Hospitality
- Information Technology
- Insurance
- Heavy Industry & Manufacturing
- Media
- Mining
- People & Culture
- Pharmaceuticals
- Policy & Public Interest
- Real Estate
- Retail
- Sports
- Telecommunications
- Transportation
- Travel
- Utilities
Healthcare - Press Releases
- 1085 Press Releases ยท
- RSS
Published on Thu 6 Mar 2025 11:04:38 UTC
RF-Cyber C-UAS Category Leader Bolsters Counter-Drone Market Presence with U.K. Office and Expert Team to Support Rapid Country Growth and Strengthen Customer Engagement
Published on Thu 6 Mar 2025 11:02:47 UTC
PORTLAND, Ore., March 6, 2025 /PRNewswire/ -- Calling all medical students drowning in UWorld questions, buried under Anki decks, and second-guessing every NBME score-there's a new way to conquer USMLE Step 1 without the burnout, the panic, or the caffeine-induced existential crises. Introducing Step 1000, a high-yield, anxiety-free study system designed to make Step 1 prep sustainable, structured, and-dare we say-actually enjoyable.
Published on Thu 6 Mar 2025 10:47:42 UTC
ALD enables lead-free MCP production with precise thin-film deposition, enhancing manufacturing yields, device performance, and lifetime value. Exosens chose Beneq's P400A batch and TFS 500 ALD systems for their scalability, precision, and ability to support development from R&D to production.
Published on Thu 6 Mar 2025 10:47:23 UTC
ALD enables lead-free MCP production with precise thin-film deposition, enhancing manufacturing yields, device performance, and lifetime value. Exosens chose Beneq's P400A batch and TFS 500 ALD systems for their scalability, precision, and ability to support development from R&D to production.
Published on Thu 6 Mar 2025 4:47:37 UTC
Milestone Commemorated with Savings for Prep and Exam Purchases
Published on Thu 6 Mar 2025 4:47:28 UTC
PITTSBURGH, March 5, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, will present at the Barclays 27th Annual Global Healthcare Conference in Miami Beach, FL on Tuesday, March 11, 2025. The company's fireside chat will begin at 2 p.m. ET.
Published on Thu 6 Mar 2025 4:47:25 UTC
-Ascend Advanced Therapies nombra a John Chiminski como presidente y a Karen Flynn como directora independiente
Published on Thu 6 Mar 2025 4:47:20 UTC
NEW YORK, March 5, 2025 /PRNewswire/ --Lucid Diagnostics Inc.(Nasdaq: LUCD)("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the closing of its previously announced registered direct offering of 13,939,331 shares of common stock at a purchase price of $1.10 per share.
Published on Thu 6 Mar 2025 4:47:16 UTC
Tampa General Hospital Cancer Institute hosted a day of keynotes, presentations and discussions at TGH Brooksville to address the challenges facing cancer patients in rural communities.
Published on Thu 6 Mar 2025 4:47:07 UTC
CHICAGO, March 5, 2025 /PRNewswire/ -- TheRobert Spadoni Scholarship for Entrepreneurs is now accepting applications from undergraduate students nationwide who demonstrate exceptional entrepreneurial potential. Established by healthcare executive Robert Spadoni, this $1,000 scholarship supports students committed to creating positive change through entrepreneurial ventures.
Published on Thu 6 Mar 2025 4:47:06 UTC
DURHAM, N.C., March 5, 2025 /PRNewswire/ --Pluto Health, a Duke-University spin-out, is now a qualified Medicaid provider in TN. The company integrates care delivery with its proprietary platform that leverages AI and data science to deliver convenient care options and health services for patients. This milestone strengthens Pluto Health's commitment to delivering comprehensive, accessible, and high-quality care to patients across the state, particularly those in underserved communities.
Published on Thu 6 Mar 2025 4:47:03 UTC
WASHINGTON, March 5, 2025 /PRNewswire/ --Paralyzed Veterans of AmericaChief Executive Officer Carl Blake releases statement following the leak of an internal memorevealing the Department of Veterans Affairs' plan to reduce its overall staffing of the department to FY 2019 levels - a decrease of more than 80,000 positions from the current staffing level.
Published on Thu 6 Mar 2025 4:46:59 UTC
With global cancer incidence rising and a strong clinical pipeline exploring combination therapies, the XPOVIO addressable market is expanding. Despite competition from CAR-T and novel therapies, XPOVIO's oral administration and unique mechanism offer differentiation.
Published on Thu 6 Mar 2025 4:46:57 UTC
The increasing occurrence of chronic and infectious diseases is the main driver of the rising demand for interferon. Furthermore, advancements in interferon production and ongoing research and development of innovative interferon therapies are key factors fueling the expansion of the interferon market from 2025 to 2032.
Published on Thu 6 Mar 2025 4:46:55 UTC
SAN FRANCISCO, March 5, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quarter and year-ended December 31, 2024 on Wednesday, March 12, 2025, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time.
Published on Thu 6 Mar 2025 4:46:52 UTC
The rising prevalence of chronic illnesses such as diabetes, cardiovascular diseases, and cancer is greatly boosting the demand for biosensors, as these conditions necessitate frequent monitoring for proper management. Likewise, the increasing need for point-of-care testing (POCT) is propelling market growth, as biosensors offer fast and convenient diagnostic solutions beyond conventional healthcare facilities.
Published on Thu 6 Mar 2025 4:46:48 UTC
MINNEAPOLIS, March 5, 2025 /PRNewswire/ -- People who take over-the-counter pain relievers after a concussion may recover faster than those who do not take pain relievers, according to a preliminary study released March 5, 2025, that will be presented at the American Academy of Neurology's 77th Annual Meeting taking place April 5-9, 2025, in San Diego and online.
Published on Thu 6 Mar 2025 4:46:46 UTC
-Drugs found to be safe and effective overall despite some risk of eye damage
Published on Thu 6 Mar 2025 4:46:43 UTC
No Shareholder Action Required at this Time
Published on Thu 6 Mar 2025 4:46:40 UTC
SUZHOU, China, March 5, 2025 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer therapies, today announced the submission of a Phase Ib clinical trial application in Australia for CS5001, its ROR1-targeting antibody-drug conjugate (ADC), in combination with first-line standard-of-care (SoC) for DLBCL. CS5001 is also being evaluated as both a monotherapy and in combination with a PD-L1 inhibitor for advanced solid tumors in an ongoing global multi-center clinical trial.
Published on Thu 6 Mar 2025 4:46:39 UTC
HONG KONG, March 5, 2025 /PRNewswire/ -- Akeso, Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce the completion of patient enrollment for its Phase III registrational clinical trial (COMPASSION-22/AK104-306) evaluating cadonilimab, the world's first PD-1/CTLA-4 bispecific antibody independently developed by the company, as an adjuvant treatment for hepatocellular carcinoma (HCC) with high recurrence risk following curative resection or ablation.
Published on Thu 6 Mar 2025 4:46:34 UTC
- Joint venture will aim to develop a cell therapy manufacturing platform through robotics and will offer access to startups and academic institutions -
Published on Thu 6 Mar 2025 4:40:50 UTC
Chelsea Handler, Naomi Watts, Katie Couric, Christy Turlington Burns, Dr. Jessica Shepherd, Dr. Sharon Malone, Stacy London, Sophia Bush, Dr. Jennifer Ashton, Hannah Bronfman, Emma Lovewell, Scott Galloway, Elaine Welteroth, Chip Conley, and more to amplify key issues shaping the future of health.
Published on Thu 6 Mar 2025 4:28:48 UTC
Deploys capital towards opportunities in AI, quantum computing, digital assets, defence, biotechnology and more
Published on Thu 27 Feb 2025 8:10:48 UTC
ZEISS VISUMAX 800 with SMILE pro software ZEISS (PRNewsfoto/Carl Zeiss Meditec)
Press Release by Industry
- All Industries
- Agriculture
- Automotive
- Banking
- Business Technology
- Construction
- Consumer Goods
- Consumer Technology
- Education
- Energy
- Entertainment & Media
- Environment
- Financial Services
- Food and Beverage
- General Business
- Healthcare
- Hospitality
- Information Technology
- Insurance
- Heavy Industry & Manufacturing
- Media
- Mining
- People & Culture
- Pharmaceuticals
- Policy & Public Interest
- Real Estate
- Retail
- Sports
- Telecommunications
- Transportation
- Travel
- Utilities